Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Pharmaceutical Industries Limited (Sun Pharma) is the largest pharmaceutical company in India and the fourth-largest specialty generic pharmaceutical company globally. Founded in 1983, the company has transitioned from a niche psychiatry-focused manufacturer into a global leader with a presence in over 100 countries and more than 40 manufacturing facilities. Sun Pharma's business strategy emphasizes a balanced portfolio of high-quality generic medicines and a growing specialty segment focused on dermatology, ophthalmology, and oncology. The company invests heavily in research and development through its innovative arm, Sun Pharma Advanced Research Company (SPARC), and has successfully commercialized major specialty brands such as Ilumya and Cequa. With a robust global supply chain and a focus on complex generics, Sun Pharma continues to be a dominant force in the United States and emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharma Industries.